Earlier this week, the Department of Justice proposed reclassifying cannabis from Schedule I to Schedule III under the Controlled Substances Act. The move follows an August 2023 recommendation from the Department of Health...more
5/6/2024
/ Agribusiness ,
Banks ,
Controlled Substances Act ,
DEA ,
Decriminalization of Marijuana ,
Department of Health and Human Services (HHS) ,
Financial Services Industry ,
FinCEN ,
Food and Drug Administration (FDA) ,
Internal Revenue Code (IRC) ,
Know Your Customers ,
Marijuana ,
Marijuana Related Businesses ,
Medical Marijuana ,
NIDA ,
Popular ,
Schedule I Drugs
Yesterday’s meeting of the New Jersey Assembly Oversight, Reform, and Federal Relations Committee provided new insights into the New Jersey cannabis industry and highlighted several developments which give cause for optimism...more